CALGARY, Alberta--(BUSINESS WIRE)--Absorb Software, maker of Absorb Learning Management System (LMS) has successfully completed its AICPA System and Organization Controls (SOC) 2 Type 2 examination ...
At 2 years, there are no significant differences with regard to clinical outcomes between the Absorb everolimus-eluting bioresorbable scaffold and the Xience everolimus-eluting stent, according to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio WASHINGTON — The Absorb bioresorbable ...
AMSTERDAM, NL — Consistent with prior trials, the risk of scaffold thrombosis was significantly higher in patients receiving the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) than an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback